EPISODE · Nov 26, 2018 · 10 MIN
Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96
from Frankly Speaking About Family Medicine · host Pri-Med
Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM. Guest: Susan Feeney, DNP, FNP-BC Landing Page: https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b
What this episode covers
Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM. Guest: Susan Feeney, DNP, FNP-BC Landing Page: https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b
NOW PLAYING
Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m